Acneiform Eruptions: Clinical Trials

207 trials for Acneiform Eruptions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

118 completed, 42 unknown, 13 not yet recruiting, 10 terminated. 207 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable207Completed 118, Unknown 42, Not yet recruiting 13, Terminated 10, Recruiting 9, Withdrawn 9, Active not recruiting 6

Follow Acneiform Eruptions: new trials by email Literature Review of Acneiform Eruptions trials Research Report on Acneiform Eruptions

Trials (filtered) newest first · largest first

All 207 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Outcomes of PRX S With Standardized Home Care in Mild-to-Moderate Facial Acne.
PRX S Facial Treatment, Standardized Home Skin Care - Acne Vulgaris
Not applicableNot yet recruitingMedical University of Silesia302026-12-012026-11-17
Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris
Clascoterone 1% cream, Adapalene 0.1% cream - Acne Vulgaris
Not applicableRecruitingPak Emirates Military Hospital1302026-10-082026-10-22
Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris
Adapalene 0.1% and Benzoyl Peroxide 2.5% gel, Sequential Radiofrequency Treatment - Acne Vulgaris
Not applicableRecruitingJeisys Medical Inc602026-09-152026-09-04
Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation
Probiotics, Placebo - Acne Vulgaris
Not applicableNot yet recruitingFoundation University Islamabad642026-09-012026-04-20
A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology
Flexible ePROM-guided Scheduling System, electronic patient reported outcome measures (ePROMs) - Chronic Dermatological Conditions, Eczema
Not applicableNot yet recruitingNational University Hospital, Singapore2502026-09-012026-07-01
Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation
Vinoperfect brightening serum - Post-inflammatory Hyperpigmentation, Post-acne Hyperpigmentation
Not applicableNot yet recruitingWeill Medical College of Cornell University202026-09-012026-10-30
Photodynamic Therapy With Topical Application of a Zn(II) Phthalocyanine (RLP068/Cl) and Red Light for the Treatment of Moderate-to-severe Acne Vulgaris
Zn(II)-phthalocyanine gel - Acne
Not applicableNot yet recruitingUniversità degli Studi di Brescia102026-08-012026-05-04
A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults
Social Renew, Placebo - Acne
Not applicableNot yet recruitingGenCanna Acquisition Corp1502026-07-012026-06-30
Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin
Cleanser, Toner, Serum - Acne
Not applicableRecruitingUSMARI Research & Innovation Centre342026-06-012026-08-06
Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial
Lactobacillus casei Shirota (LcS) Probiotic Drink, Skimmed Milk Control Drink - Skin Inflammation, Immunosenescence
Not applicableRecruitingKing's College London302026-04-282026-05-08
Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)
topical dutasteride - Acne Vulgaris
Not applicableNot yet recruitingAssiut University502026-04-012026-02-19
Sebum Metabolomics and Lipidomics for Clinical Applications
Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment) - Acne, Atopic Dermatitis
Not applicableNot yet recruitingNational Taiwan University Hospital2002026-04-012026-04-24
Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars
Juläine, Sterile Saline (Placebo) - Acne Scars
Not applicableActive not recruitingNordberg Medical AB552026-03-162026-11-16
Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris
DispersinB Acne Cleanser - Acne Vulgaris on the Face
Not applicableNot yet recruitingKane Biotech Inc242026-01-302025-05-13
Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris
Dextrose Phonophoresis, Ultrasound, Dextrose Topical application - Acne Vulgaris
Not applicableCompletedMTI University1152025-11-012025-12-05
Adjunctive 308-nm Excimer Light With Oral Azithromycin for Inflammatory Acne
308-nm Excimer Light, Azithromycin - Acne Vulgaris
Not applicableCompletedMahmoud Rageh322025-10-122026-08-21
A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
Use of Barrier Building Moisturizer - Acne Vulgaris
Not applicableCompletedKenvue Brands LLC472025-10-072026-08-19
AI-Generated Acne Vulgaris Learning Material Study
Artificial Intelligence-Generated Acne Vulgaris Educational Material, Turkish Dermatology Association Acne Vulgaris Educational Material - Acne Vulgaris, Medical Education
Not applicableCompletedHasan Durmuş1902025-09-152026-06-16
Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate
lipid profile - Acne Vulgaris
Not applicableNot yet recruitingSohag University1002025-08-012025-07-14
Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study
Active CAP therapy, sham CAP therapy, standard care based on the JAAD acne guidelines - Acne Vulgaris
Not applicableRecruitingShenyang Medical College2202025-07-262026-01-02

Showing 20 of 207. Sign in to see all of them.

Narrower conditions

Acne Vulgaris (203)  ·  Cicatrix (11)  ·  Dermatitis, Atopic (6)  ·  Rosacea (6)  ·  Skin Diseases (6)  ·  Dermatitis (5)  ·  Eczema (4)  ·  Facies (4)  ·  Psoriasis (4)  ·  Acne Keloid (3)  ·  Dermatitis, Seborrheic (3)  ·  Melanosis (3)  ·  Cough (2)  ·  Diarrhea (2)

Broader conditions

Skin and Connective Tissue Diseases (207)  ·  Sebaceous Gland Diseases (202)  ·  Skin Diseases (201)  ·  Pathological Conditions, Signs and Symptoms (24)  ·  Pathologic Processes (20)  ·  Fibrosis (11)  ·  Skin Diseases, Eczematous (11)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Immune System Diseases (9)  ·  Dermatitis (8)  ·  Hypersensitivity (8)  ·  Hypersensitivity, Immediate (8)  ·  Genetic Diseases, Inborn (7)  ·  Skin Diseases, Genetic (7)

Interventions

Adapalene (8)  ·  Gels (8)  ·  Benzoyl Peroxide (6)  ·  Isotretinoin (6)  ·  Percutaneous Collagen Induction (4)  ·  Lasers, Solid-State (3)  ·  Photochemotherapy (3)  ·  Probiotics (3)  ·  Salicylic Acid (3)  ·  Tretinoin (3)  ·  Triamcinolone (3)  ·  clindamycin phosphate benzoyl peroxide combination (3)  ·  Aminolevulinic Acid (2)  ·  Intense Pulsed Light Therapy (2)  ·  Lasers (2)

Sponsors

Integrative Skin Science and Research (8)  ·  Seoul National University Hospital (7)  ·  Cosmetique Active International (5)  ·  Pierre Fabre Dermo Cosmetique (5)  ·  Cutera Inc. (4)  ·  Massachusetts General Hospital (4)  ·  Northwestern University (4)  ·  Sebacia, Inc. (4)  ·  Shanghai Dermatology Hospital (4)  ·  Sohag University (4)  ·  Actavis Mid-Atlantic LLC (3)  ·  Assiut University (3)  ·  Cairo University (3)  ·  Johnson & Johnson Consumer Inc. (J&JCI) (3)  ·  University of Miami (3)

Countries

United States (77)  ·  Egypt (17)  ·  China (15)  ·  Brazil (8)  ·  South Korea (8)  ·  France (7)  ·  Canada (6)  ·  Denmark (5)  ·  India (5)  ·  Poland (5)  ·  Spain (5)  ·  Pakistan (4)  ·  Israel (3)  ·  Indonesia (2)  ·  Italy (2)

Top investigators

Amy Paller, MD (3)  ·  Raja Sivamani, MD MS AP (3)  ·  Alur S. Kumar, MD (2)  ·  Anilkumar Malik, MD (2)  ·  Bela J. Shah, MD (2)  ·  Dae Hun Suh, MD (2)  ·  Hemanji R. Jerajani, MD (2)  ·  Jayadev Betkerur, MD (2)  ·  Jayesh Kothari, MD (2)  ·  Kailash Bhatia, MD (2)  ·  Karigi Siddalingappa, MD (2)  ·  Leelavathy B., MD (2)  ·  Lily Jiang, Ph.D. (2)  ·  Manoj K. Parekh, MD (2)  ·  Mukta Sachdev, MD (2)

Results publications

PMID 17314442, PMID 17616769, PMID 20404229, PMID 22168326, PMID 22253996, PMID 22678562, PMID 23710844, PMID 26017816, PMID 29691143, PMID 30296534, PMID 31420849, PMID 31896400, PMID 33150170, PMID 35789996, PMID 36946749, PMID 37998335, PMID 38034535, PMID 38896602, PMID 38912192, PMID 39529772, PMID 40029154, PMID 40246799, PMID 40321085

NIH funding

2019 (1), 2023 (1), R01HD065029 (1)